Professors Edward Tuddenham and Mike Laffan wrote in the British Medical Journal that: "Recombinant factor VIII is therefore the treatment of choice, given its freedom from viruses derived from plasma..."
Chronology Information
Date:
Chapter/issue
Access to Treatment
Key Person(s)
Professor Edward G D Tuddenham